Showing results (661-670 of 10,067) with videos related to
Sort By:
Pageof 1,007
Current Pharmaceutical Design|August 20, 2009
Imaging the neural effects of cannabinoids: current status and future opportunities for psychopharmacologyS Bhattacharyya, J A Crippa, R Martin-Santos, et al.Current Pharmaceutical Design|August 20, 2009
Neuroimaging and genetics of antidepressant response to sleep deprivation: implications for drug developmentFrancesco Benedetti, Enrico SmeraldiCurrent Pharmaceutical Design|August 20, 2009
Targeting phosphatidylserine in anti-cancer therapyHeidi Kenis, Chris ReutelingspergerCurrent Pharmaceutical Design|August 20, 2009
Therapeutic angiogenesis for peripheral artery diseases by autologous bone marrow cell transplantationSatoaki Matoba, Hiroaki MatsubaraCurrent Pharmaceutical Design|August 20, 2009
Cardiac applications for human pluripotent stem cellsYuji Shiba, Kip D Hauch, Michael A LaflammeCurrent Pharmaceutical Design|September 16, 2009
Turning REST/NRSF dysfunction in Huntington's disease into a pharmaceutical targetDorotea Rigamonti, Cesare Mutti, Chiara Zuccato, et al.Current Pharmaceutical Design|September 17, 2009
Blood-brain interfaces and bilirubin-induced neurological diseasesJ F Ghersi-Egea, S Gazzin, N StrazielleCurrent Pharmaceutical Design|September 17, 2009
Redox state, oxidative stress, and molecular mechanisms of protective and toxic effects of bilirubin on cellsGianluca Tell, Stefano GustincichCurrent Pharmaceutical Design|September 17, 2009
Contribution of inflammatory processes to nerve cell toxicity by bilirubin and efficacy of potential therapeutic agentsAdelaide Fernandes, Dora BritesPageof 1,007